New Drug Approved for Early Alzheimer’s

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease but also carry safety risks.

source https://www.nytimes.com/2024/07/02/health/alzheimers-treatment-kisunla-donanemab.html